Illumina Sets Up A $1.0 Billion Commercial Paper Program, With No Notes Outstanding Yet
An 8-K shows the genomics company signed agreements with three dealers to borrow short-term cash for general corporate purposes.
Illumina has created an unsecured commercial paper program — short-term IOUs sold to investors — that caps notes outstanding at any time at $1.0 billion, according to an 8-K filed Tuesday. The company entered into the documentation on October 8, and no notes were outstanding as of the report.
What the 8-K says
Illumina may issue the notes under an exemption from registration in Section 4(a)(2) of the Securities Act of 1933. The company can borrow, repay and borrow again under the program, as long as the total outstanding stays within the $1.0 billion cap.
Proceeds from any issuance are expected to go to general corporate purposes. Maturities will vary but may not exceed 397 days from the date of issue.
The notes will be sold on customary commercial paper market terms. They will either be issued at a discount from par, or issued at par and carry fixed or floating interest rates.
Three commercial paper dealers will initially act under the program, each through its own dealer agreement with Illumina. A national bank will serve as issuing and paying agent. Each dealer will either buy the notes from Illumina or arrange their sale to one or more purchasers.
The filing says the dealer agreements are substantially identical except for the parties and the notice provisions. A form of the agreement is attached as Exhibit 10.1. The filing also says some dealers and their affiliates have provided banking and advisory services to Illumina and received customary fees.
What it changes
The program gives Illumina a standing channel for short-term borrowing. Nothing has been drawn, so the company's debt is unchanged by this filing.
The notes are not registered under the Securities Act or state securities laws. They can be offered or sold in the United States only under an exemption.
In after-hours trading Tuesday, Illumina shares were at $272.01, up 0.31% from the regular-session close of $271.18. That reading came before the filing was accepted at 4:48 p.m. ET, so it is not a reaction to the news.
What to watch
The first sign of use will be a later filing or disclosure showing notes outstanding. As of the report, there were none.
Chief Financial Officer Ankur Dhingra signed the filing on October 13; the program's $1.0 billion ceiling is the only limit it states.
Sources
- 8-K Filing — ILLUMINA, INC. (ILMN) — SEC EDGAR